Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Honey | 1 | 2021 | 11 | 0.790 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2021 | 1572 | 0.590 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2203 | 0.460 |
Why?
|
Liver Transplantation | 4 | 2002 | 2119 | 0.300 |
Why?
|
Lymphocytosis | 2 | 2002 | 119 | 0.260 |
Why?
|
Liver | 5 | 2005 | 7474 | 0.240 |
Why?
|
Hepatitis, Autoimmune | 2 | 2002 | 141 | 0.210 |
Why?
|
Pathology, Surgical | 1 | 2003 | 155 | 0.210 |
Why?
|
Resins, Synthetic | 1 | 2021 | 28 | 0.200 |
Why?
|
Cytodiagnosis | 1 | 2005 | 435 | 0.190 |
Why?
|
Carcinoma, Lobular | 1 | 2005 | 484 | 0.190 |
Why?
|
Colitis | 3 | 2004 | 1170 | 0.180 |
Why?
|
Cholestasis | 2 | 2017 | 378 | 0.170 |
Why?
|
Carcinoma in Situ | 1 | 2005 | 806 | 0.170 |
Why?
|
Biopsy, Fine-Needle | 1 | 2003 | 1094 | 0.160 |
Why?
|
Ampulla of Vater | 1 | 2018 | 141 | 0.160 |
Why?
|
Living Donors | 1 | 2001 | 620 | 0.140 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1257 | 0.140 |
Why?
|
Liver Cirrhosis | 2 | 2002 | 1863 | 0.130 |
Why?
|
Fluoroscopy | 1 | 2017 | 924 | 0.110 |
Why?
|
Pancreaticoduodenectomy | 1 | 2016 | 503 | 0.110 |
Why?
|
Antioxidants | 1 | 2021 | 1663 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2017 | 567 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-fos | 3 | 1999 | 575 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1261 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2006 | 20822 | 0.080 |
Why?
|
Capsaicin | 3 | 1999 | 231 | 0.080 |
Why?
|
Models, Statistical | 1 | 2003 | 5102 | 0.080 |
Why?
|
Intestinal Mucosa | 2 | 2018 | 3036 | 0.080 |
Why?
|
Trigeminal Nuclei | 2 | 1999 | 41 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2002 | 2425 | 0.080 |
Why?
|
N-Methylaspartate | 2 | 1997 | 231 | 0.070 |
Why?
|
Collagen | 3 | 2004 | 2689 | 0.070 |
Why?
|
Observer Variation | 2 | 2018 | 2593 | 0.060 |
Why?
|
Transplantation, Homologous | 3 | 2002 | 4776 | 0.060 |
Why?
|
Graft Rejection | 3 | 2002 | 4397 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 1997 | 916 | 0.060 |
Why?
|
Cholangitis | 1 | 2005 | 108 | 0.060 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2005 | 295 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2002 | 15295 | 0.060 |
Why?
|
Biopsy | 5 | 2018 | 6756 | 0.060 |
Why?
|
Paneth Cells | 1 | 2002 | 99 | 0.050 |
Why?
|
Metaplasia | 1 | 2002 | 313 | 0.050 |
Why?
|
Gene Amplification | 1 | 2006 | 1063 | 0.050 |
Why?
|
Ischemic Attack, Transient | 2 | 1997 | 935 | 0.050 |
Why?
|
Trigeminal Caudal Nucleus | 1 | 1999 | 18 | 0.050 |
Why?
|
Ileum | 1 | 2002 | 565 | 0.050 |
Why?
|
Recurrence | 2 | 2002 | 8340 | 0.040 |
Why?
|
Benzopyrans | 1 | 1999 | 64 | 0.040 |
Why?
|
Barbiturates | 1 | 1999 | 114 | 0.040 |
Why?
|
Diarrhea | 2 | 2004 | 1348 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5256 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 1999 | 201 | 0.040 |
Why?
|
Serotonin Receptor Agonists | 1 | 1999 | 152 | 0.040 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1997 | 40 | 0.040 |
Why?
|
Nitroarginine | 1 | 1997 | 66 | 0.040 |
Why?
|
Dura Mater | 1 | 1999 | 291 | 0.040 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1997 | 146 | 0.040 |
Why?
|
Middle Aged | 10 | 2017 | 213383 | 0.040 |
Why?
|
Fatty Liver | 1 | 2002 | 727 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2006 | 2416 | 0.030 |
Why?
|
GABA Agents | 1 | 1995 | 42 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2005 | 2969 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2617 | 0.030 |
Why?
|
Female | 14 | 2017 | 380194 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15076 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19905 | 0.030 |
Why?
|
Colonoscopy | 1 | 2002 | 1367 | 0.030 |
Why?
|
Valproic Acid | 1 | 1995 | 445 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2005 | 3690 | 0.030 |
Why?
|
Protein Kinase C | 1 | 1997 | 1227 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2018 | 77449 | 0.030 |
Why?
|
Male | 14 | 2017 | 350118 | 0.030 |
Why?
|
Guinea Pigs | 3 | 1999 | 1386 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 868 | 0.030 |
Why?
|
Adult | 8 | 2017 | 214055 | 0.020 |
Why?
|
Corpus Striatum | 1 | 1997 | 1221 | 0.020 |
Why?
|
Graft Survival | 1 | 2001 | 3737 | 0.020 |
Why?
|
Humans | 14 | 2018 | 744343 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2003 | 3528 | 0.020 |
Why?
|
Aged | 7 | 2017 | 163280 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2006 | 8428 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 8949 | 0.020 |
Why?
|
Piperazines | 1 | 1999 | 2488 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2000 | 4149 | 0.020 |
Why?
|
Tritium | 2 | 1997 | 745 | 0.020 |
Why?
|
Autoradiography | 2 | 1997 | 745 | 0.020 |
Why?
|
Fixatives | 1 | 2006 | 94 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3798 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2006 | 299 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3474 | 0.020 |
Why?
|
Formaldehyde | 1 | 2006 | 353 | 0.020 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.010 |
Why?
|
Mice, Mutant Strains | 2 | 1997 | 1866 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
Aged, 80 and over | 4 | 2017 | 57776 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2005 | 528 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1997 | 2327 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2016 | 63114 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2002 | 68 | 0.010 |
Why?
|
Venules | 1 | 2002 | 165 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT1D | 1 | 1999 | 9 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2649 | 0.010 |
Why?
|
Oxadiazoles | 1 | 1999 | 93 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1641 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2002 | 1799 | 0.010 |
Why?
|
Serotonin Antagonists | 1 | 1999 | 144 | 0.010 |
Why?
|
Child | 2 | 2005 | 77709 | 0.010 |
Why?
|
Adolescent | 2 | 2005 | 85781 | 0.010 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1997 | 70 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1999 | 1157 | 0.010 |
Why?
|
Vasculitis | 1 | 2002 | 519 | 0.010 |
Why?
|
Hydroxyl Radical | 1 | 1997 | 78 | 0.010 |
Why?
|
Necrosis | 1 | 2002 | 1643 | 0.010 |
Why?
|
Kainic Acid | 1 | 1997 | 199 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2004 | 1063 | 0.010 |
Why?
|
Dizocilpine Maleate | 1 | 1997 | 176 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1997 | 242 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1997 | 374 | 0.010 |
Why?
|
Receptors, Glutamate | 1 | 1997 | 232 | 0.010 |
Why?
|
Reperfusion | 1 | 1997 | 284 | 0.010 |
Why?
|
Bicuculline | 1 | 1995 | 99 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29063 | 0.010 |
Why?
|
GABA Antagonists | 1 | 1995 | 128 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 1995 | 230 | 0.010 |
Why?
|
Baclofen | 1 | 1995 | 129 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2002 | 1026 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.010 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1997 | 449 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1997 | 1827 | 0.010 |
Why?
|
Blood Proteins | 1 | 1999 | 1124 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7149 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1999 | 1767 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 40561 | 0.010 |
Why?
|
Tyrosine | 1 | 1997 | 1461 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 895 | 0.010 |
Why?
|
Animals | 6 | 1999 | 168757 | 0.010 |
Why?
|
Brain Stem | 1 | 1995 | 846 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 56430 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 1997 | 21827 | 0.010 |
Why?
|
Binding Sites | 1 | 1997 | 6114 | 0.010 |
Why?
|
Survival Rate | 1 | 2002 | 12788 | 0.000 |
Why?
|
Mice | 3 | 1997 | 81183 | 0.000 |
Why?
|
Algorithms | 1 | 2005 | 13881 | 0.000 |
Why?
|
Blood Pressure | 1 | 1999 | 8554 | 0.000 |
Why?
|
Mice, Knockout | 1 | 1997 | 14557 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2004 | 39050 | 0.000 |
Why?
|
Apoptosis | 1 | 1997 | 9727 | 0.000 |
Why?
|
Rats | 1 | 1997 | 24260 | 0.000 |
Why?
|
Time Factors | 1 | 1997 | 40075 | 0.000 |
Why?
|
Brain | 1 | 1997 | 26385 | 0.000 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_